Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · Real-Time Price · USD

3.280

+0.050 (1.55%)

At close: Jan 2, 2026, 4:00 PM EST

3.370

+0.090 (2.74%)

After-hours: Jan 2, 2026, 5:01 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2012 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2012 - 2016
T-cell Therapies	5.00K	Log In	Log In	Log In	Log In	Upgrade
T-cell Therapies Growth	-99.83%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2012 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2012 - 2016
United States	5.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-99.83%	Log In	Log In	Log In	Log In	Upgrade